Varex/$VREX

1D1W1MYTD1Y5YMAX

About Varex

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
Ticker
$VREX
Sector
Health
Primary listing
NASDAQ
Employees
2,500

Varex Metrics

BasicAdvanced
$778M
35.50
$0.52
0.88
-

What the Analysts think about Varex

Analyst ratings (Buy, Hold, Sell) for Varex stock.
Analyst projections of the future price of Varex stock.

Bulls say / Bears say

Teledyne has agreed to acquire Varex Imaging for $18.90 per share in cash, valuing the transaction at approximately $1.1 billion and representing a significant premium over recent trading levels (Teledyne)
Varex’s Industrial segment revenue grew 26% year-over-year to $77 million in Q3 FY26, driven by robust demand for cargo and vehicle inspection systems (SEC)
The company generated $21 million of operating cash flow in Q3 FY26, bolstered by $17 million in IEEPA tariff refunds, improving liquidity ahead of the merger close (SEC)
Medical segment revenue fell 6% year-over-year to $134 million in Q3 FY26, signaling softness in its core healthcare imaging business (SEC)
The pending merger is subject to regulatory and shareholder approvals and includes termination rights, posing execution and integration risks that could jeopardize deal completion (Teledyne)
Cash and equivalents declined to $99 million at Q3-end from $155 million at the end of fiscal 2025, narrowing liquidity as working capital needs rise (SEC)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.

Varex Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Varex Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Varex

Funds
Fund name
Fund size
$VREX weighting
SPDR Russell 2000 US Small Cap€R2US
€4.8B0.02%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.